SmartSKN Launches K-OWN: The World’s first AI custom Korean skincare platform powered by robots
BOSTON, March 14, 2025 /PRNewswire/ -- SmartSKN, a leader in K-Beauty technology, announces the launch of K-OWN. This AI-driven platform...
Day: March 14, 2025
Nimblemind.ai Raises $2.5M to Unlock AI-Ready Clinical Data for Healthcare Providers
CHICAGO, March 14, 2025 /PRNewswire/ -- Nimblemind.ai, an AI-powered data infrastructure platform designed to help healthcare providers structure and leverage...
AI-Powered Healthcare: How ADLINK’s Medical Innovations at HIMSS 2025 Are Transforming Patient Care
Celebrating 30 Years of Innovation Excellence with Advanced OEM Solutions for Healthcare Summary: Successful Showcase: ADLINK's latest AI-driven medical solutions...
CTG Appoints Dan Stoke Vice President of U.S. Healthcare Business
Growth-Oriented Healthcare IT Leader to Build on CTG’s Strong Industry Legacy; Drive Growth, Innovation, and Market Expansion BUFFALO, N.Y.--(BUSINESS WIRE)--CTG,...
TruBridge Announces Participation in the KeyBanc Capital Markets Healthcare Forum
MOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:TBRG), a healthcare solutions company, today announced that management will participate in the KeyBanc Capital Markets...
WTWH Healthcare, a WTWH Media Company, Announces 2025 Aspect Awards Winners
CLEVELAND, March 14, 2025 /PRNewswire/ -- WTWH Healthcare, a WTWH Media company, is proud to announce the winners of the...
FLORIDA SOUTHERN COLLEGE NAMES BRITTANY BEHRENS, MSN, RN, CNE, CHSE, THE MAIDA BADCOCK POU ENDOWED CHAIR IN NURSING SIMULATION
LAKELAND, Fla., March 14, 2025 /PRNewswire/ -- Florida Southern College is excited to announce Brittany Behrens, MSN, RN, CNE, CHSE, as...
BioSurfaces and Morphocell Technologies Announce Collaboration to Explore Therapeutic Applications of Bio-Spun™ Material
ASHLAND, Mass., March 14, 2025 /PRNewswire/ -- BioSurfaces, a leader in advanced nanofiber materials, and Morphocell Technologies, a regenerative medicine...
Biolexis Therapeutics Unlocks a New Frontier in GLP-1 Receptor Activation
CryoEM Confirms a First-in-Class Allosteric Binding Mode, Validating MolecuLern™ AI-Driven Discovery LEHI, Utah, March 14, 2025 /PRNewswire/ -- Biolexis Therapeutics has achieved...
Happy World Sleep Day: Discover the benefits of a good night’s sleep and how Garmin smartwatches can help
Garmin Connect data shows users have been sleeping better over the last year OLATHE, Kan., March 14, 2025 /PRNewswire/ --...
Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal
UroShield Cited as Effective in Preventing CAUTIs and Blockages, Having a Major Impact on Quality of Life and Reducing Healthcare...
Polyrizon Signs Non– Binding LOI to Expand its Innovative Intranasal Drug Delivery Platform for Psychedelic-Based Treatments
Raanana, Israel, March 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development stage biotech...
Hepion Pharmaceuticals Announces Reverse Stock Split
Shares Expected to Begin Trading on Split-Adjusted Basis on March 18, 2025 MORRISTOWN, N.J., March 14, 2025 (GLOBE NEWSWIRE) --...
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
Optimal therapeutic targeting of cancer involves clonal signals which are expressed within all cancer cellsGradalis applies a novel clinically relevant...
Autonomix Medical, Inc. Advances Toward U.S. Clinical Trials in 2025 with Completed Integration of Apex 6 Generator for Transvascular Ablation
Company successfully meets key milestone with design lock that integrates and finalizes enhancements to its licensed Apex 6 Radiofrequency (“RF”)...
Tiziana Life Sciences Regains Compliance with Nasdaq Listing Minimum Bid Price Rule
NEW YORK, March 14, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology...
Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108
Positive preliminary data from all five single ascending dose (SAD) cohorts and first three completed multiple ascending dose (MAD) cohorts...
Psyched Wellness Provides Comprehensive Investor Update
Toronto, Ontario--(Newsfile Corp. - March 14, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or...
Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.
Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 14, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed an...